 LA JOLLA, Calif., March 11, 2021 GLOBE NEWSWIRE -- via InvestorWire Artelo Biosciences, Inc. NASDAQ: ARTL, a clinical stage biopharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory Gorgas, Chief Executive Officer of Artelo Biosciences, will be presenting at the Q1 Virtual Investor Summit. 